STOCK TITAN
  1. Home
  2. News
  3. ASXC

Asensus Surgical Inc - ASXC STOCK NEWS

Welcome to our dedicated news page for Asensus Surgical (Ticker: ASXC), a resource for investors and traders seeking the latest updates and insights on Asensus Surgical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Asensus Surgical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Asensus Surgical's position in the market.

News
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
Rhea-AI Summary
Asensus Surgical, Inc. announces a non-binding letter of intent with KARL STORZ SE & Co. KG for a potential acquisition, including up to $20 million in bridge financing. KARL STORZ proposes to acquire 100% of Asensus' common stock for $0.35 per share, a 66.7% premium. The exclusivity period allows for diligence and negotiation of a definitive merger agreement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.71%
Tags
acquisition
-
News
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) reported its operating and financial results for Q4 and full year 2023, showcasing growth in surgical procedures and revenue. The company completed evaluations of its LUNA Surgical System and saw an increase in Senhance Surgical System usage globally. With a revenue of $8.6 million for 2023 and cash reserves of $21.1 million, Asensus Surgical aims for significant milestones in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.25%
Tags
earnings
-
News
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) to release Q4 and full year 2023 financial results on March 21, 2024. Conference call scheduled for discussing the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
earnings
News
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference with Shameze Rampertab, EVP and CFO, presenting virtually on March 12, 2024. The webcast will be available on the company's investor relations page for 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
conferences
-
News
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) celebrates surpassing 1,000 successful cases with Senhance Surgical System at three international hospitals, showcasing the growing acceptance and confidence in their innovative technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
none
-
News
Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program
Rhea-AI Summary
Asensus Surgical, Inc. announced that Nagoya University Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in their Pediatric Surgery Department, making it the first pediatric installation in Japan and the fourth globally for 2023. The system is specifically equipped to meet the demands of pediatric surgery, offering specialized instrumentation and advanced clinical intelligence to reduce invasiveness and increase precision. Dr. Hiroo Uchida of the Department of Pediatric Surgery at Nagoya University Hospital stated that the system provides a valuable solution for pediatric surgery, with reusable 3mm instruments and instinctive camera control. Asensus Surgical's President and CEO, Anthony Fernando, expressed excitement to work with Nagoya University Hospital and extend the benefits of the Senhance System in Japan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.06%
Tags
none
News
Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) provided a preliminary 2023 year-end corporate update, reporting over 3,550 procedures performed globally, 14% growth in procedures compared to 2022, initiation of eight Senhance Surgical Programs, unaudited cash of approximately $21.0 million on December 31, 2023, and unaudited revenue of approximately $8.2 - $8.8 million for 2023. Fourth quarter highlights include over 835 procedures globally using the Senhance® Surgical System, initiation of five Senhance Surgical Programs, and unaudited revenue of approximately $5.1 - $5.7 million. Asensus Surgical President and CEO, Anthony Fernando, expressed optimism for the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.37%
Tags
none
-
News
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announced a key development milestone for LUNA™, its second-generation surgical robotic system. Surgeons applauded the innovative capabilities of LUNA during an in vivo evaluation in porcine models. The system's impressive arm range of motion, instrument dexterity, and ergonomic design were highlighted, with positive feedback from participating surgeons. LUNA is designed to elevate the standards of robotic-assisted surgery and is currently under development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
none
-
News
Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
News
Asensus Announces Sale of Senhance Robotic System in Romania
Rhea-AI Summary
Asensus Surgical, Inc. (NYSE American: ASXC) announced the sale of a Senhance® Surgical System to be placed in Louis Turcanu Clinical Emergency Hospital for Children in Timisoara, Romania. The system, designed for pediatric procedures, aims to enhance outcomes and patient well-being. The hospital's Department of Pediatrics is eager to explore new possibilities and continually improve surgical technology for the betterment of patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.9%
Tags
none
Stock ASXC logo
Asensus Surgical Inc

NYSE:ASXC

ASXC Rankings

#4544 Ranked by Market Cap
#4599 Ranked by Stock Gains
N/A Ranked by Dividends

ASXC Stock Data

70.99M
266.72M
1.97%
9.32%
6.53%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Durham

About ASXC

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.